Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion type Assertion NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_head.
- NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion description "[Based on the broad spectrum of methods employed to characterize this general strategy, PL-targeted approaches may be considered as a paradigm of future genetic treatments of cardiac disorders, although the differences between animal models and humans must be kept in mind.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_provenance.
- NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion evidence source_evidence_literature NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_provenance.
- NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion SIO_000772 15024585 NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_provenance.
- NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion wasDerivedFrom befree-20140225 NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_provenance.
- NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_assertion wasGeneratedBy ECO_0000203 NP806550.RABQ0gvKR4UuaoYc1V3nH3u1w4HHYvFTxRbJFCGpNgHB4130_provenance.